相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Expression of Genomic Instability-Related Molecules: Cyclin F, RRM2 and SPDL1 and Their Prognostic Significance in Pancreatic Adenocarcinoma
Anna Klimaszewska-Wisniewska et al.
CANCERS (2021)
M1 Macrophage-Derived Exosomes Loaded with Gemcitabine and Deferasirox against Chemoresistant Pancreatic Cancer
Yongmei Zhao et al.
PHARMACEUTICS (2021)
Targeting AKT/mTOR in Oral Cancer: Mechanisms and Advances in Clinical Trials
Choudhary Harsha et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Broussoflavonol B from Broussonetia kazinoki Siebold Exerts Anti-Pancreatic Cancer Activity through Downregulating FoxM1
Ji Hye Jeong et al.
MOLECULES (2020)
PI(3,4)P2 Signaling in Cancer and Metabolism
Luca Gozzelino et al.
FRONTIERS IN ONCOLOGY (2020)
PCNA-Mediated Degradation of p21 Coordinates the DNA Damage Response and Cell Cycle Regulation in Individual Cells
Caibin Sheng et al.
CELL REPORTS (2019)
Dihydrosanguinarine suppresses pancreatic cancer cells via regulation of mut-p53/WT-p53 and the Ras/Raf/Mek/Erk pathway
Wu Si-zhi et al.
PHYTOMEDICINE (2019)
Acetylation regulates ribonucleotide reductase activity and cancer cell growth
Guo Chen et al.
NATURE COMMUNICATIONS (2019)
Targeting the PI3K/AKT/mTOR pathway in biliary tract cancers: A review of current evidences and future perspectives
Francesca Corti et al.
CANCER TREATMENT REVIEWS (2019)
The Upstream Pathway of mTOR-Mediated Autophagy in Liver Diseases
Haojie Wang et al.
CELLS (2019)
Precision design of nanomedicines to restore gemcitabine chemosensitivity for personalized pancreatic ductal adenocarcinoma treatment
Xiao Zhao et al.
BIOMATERIALS (2018)
The activation of STIM1 mediates S-phase arrest and cell death in paraquat induced acute lung intoxication
Hanting Fan et al.
TOXICOLOGY LETTERS (2018)
siRNA Knockdown of RRM2 Effectively Suppressed Pancreatic Tumor Growth Alone or Synergistically with Doxorubicin
Shuquan Zheng et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2018)
Yes-associated protein (YAP) in pancreatic cancer: at the epicenter of a targetable signaling network associated with patient survival
Enrique Rozengurt et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2018)
3rd St. Gallen EORTC Gastrointestinal Cancer Conference: Consensus recommendations on controversial issues in the primary treatment of pancreatic cancer
Manfred P. Lutz et al.
EUROPEAN JOURNAL OF CANCER (2017)
Inhibition of Isoprenylcysteine Carboxylmethyltransferase Induces Cell-Cycle Arrest and Apoptosis through p21 and p21-Regulated BNIP3 Induction in Pancreatic Cancer
Kanjoormana Aryan Manu et al.
MOLECULAR CANCER THERAPEUTICS (2017)
Shortage of dNTPs underlies altered replication dynamics and DNA breakage in the absence of the APC/C cofactor Cdh1
J. Garzon et al.
ONCOGENE (2017)
Inhibitors of cyclin-dependent kinases as cancer therapeutics
Steven R. Whittaker et al.
PHARMACOLOGY & THERAPEUTICS (2017)
Long non-coding RNA SNHG20 promotes non-small cell lung cancer cell proliferation and migration by epigenetically silencing of P21 expression
Zhenyao Chen et al.
CELL DEATH & DISEASE (2017)
DNA damage during S-phase mediates the proliferation-quiescence decision in the subsequent G1 via p21 expression
Alexis R. Barr et al.
NATURE COMMUNICATIONS (2017)
Nucleoside Analogue Triphosphates Allosterically Regulate Human Ribonucleotide Reductase and Identify Chemical Determinants That Drive Substrate Specificity
Andrew J. Knappenberger et al.
BIOCHEMISTRY (2016)
ATR-CHK1-E2F3 signaling transactivates human ribonucleotide reductase small subunit M2 for DNA repair induced by the chemical carcinogen MNNG
Chaoju Gong et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS (2016)
p21(WAF1) Mediates Cell-Cycle Inhibition, Relevant to Cancer Suppression and Therapy
Wafik S. El-Deiry
CANCER RESEARCH (2016)
PTEN alterations of the stromal cells characterise an aggressive subpopulation of pancreatic cancer with enhanced metastatic potential
Martin Wartenberg et al.
EUROPEAN JOURNAL OF CANCER (2016)
Defining the consequences of genetic variation on a proteome-wide scale
Joel M. Chick et al.
NATURE (2016)
BRCA1-regulated RRM2 expression protects glioblastoma cells from endogenous replication stress and promotes tumorigenicity
Rikke D. Rasmussen et al.
NATURE COMMUNICATIONS (2016)
E2F1 promote the aggressiveness of human colorectal cancer by activating the ribonucleotide reductase small subunit M2
Zejun Fang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2015)
Hesperidin inhibits HeLa cell proliferation through apoptosis mediated by endoplasmic reticulum stress pathways and cell cycle arrest
Yaoxian Wang et al.
BMC CANCER (2015)
Ribonucleotide reductase M2 is a promising molecular target for the treatment of oral squamous cell carcinoma
Kazuki Iwamoto et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2015)
Ribonucleotide Reductase Subunit M2 Predicts Survival in Subgroups of Patients with Non-Small Cell Lung Carcinoma: Effects of Gender and Smoking Status
Vei Mah et al.
PLOS ONE (2015)
Targeting the PI3K/Akt signaling pathway in gastric carcinoma: A reality for personalized medicine?
Shikha Satendra Singh et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2015)
Prognostic and therapeutic significance of ribonucleotide reductase small subunit M2 in estrogen-negative breast cancers
Hang Zhang et al.
BMC CANCER (2014)
Increased expression of RRM2 by human papillomavirus E7 oncoprotein promotes angiogenesis in cervical cancer
N. Wang et al.
BRITISH JOURNAL OF CANCER (2014)
Making new contacts: the mTOR network in metabolism and signalling crosstalk
Mitsugu Shimobayashi et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2014)
Excision repair cross-complementing gene-1, ribonucleotide reductase subunit M1, ribonucleotide reductase subunit M2, and human equilibrative nucleoside transporter-1 expression and prognostic value in biliary tract malignancy
Sarah B. Fisher et al.
CANCER (2013)
An analysis of human equilibrative nucleoside transporter-1, ribonucleoside reductase subunit M1, ribonucleoside reductase subunit M2, and excision repair cross-complementing gene-1 expression in patients with resected pancreas adenocarcinoma
Sarah B. Fisher et al.
CANCER (2013)
RRM2 Regulates Bcl-2 in Head and Neck and Lung Cancers: A Potential Target for Cancer Therapy
Mohammad Aminur Rahman et al.
CLINICAL CANCER RESEARCH (2013)
Ribonucleotide reductase small subunit M2 serves as a prognostic biomarker and predicts poor survival of colorectal cancers
Xiyong Liu et al.
CLINICAL SCIENCE (2013)
Suppression of Nucleotide Metabolism Underlies the Establishment and Maintenance of Oncogene-Induced Senescence
Katherine M. Aird et al.
CELL REPORTS (2013)
Cyclin F-Mediated Degradation of Ribonucleotide Reductase M2 Controls Genome Integrity and DNA Repair
Vincenzo D'Angiolella et al.
CELL (2012)
Differential Expression of ERCC1 in Pancreas Adenocarcinoma: High Tumor Expression is Associated with Earlier Recurrence and Shortened Survival after Resection
Shishir K. Maithel et al.
ANNALS OF SURGICAL ONCOLOGY (2011)
siRNA Knockdown of Ribonucleotide Reductase Inhibits Melanoma Cell Line Proliferation Alone or Synergistically with Temozolomide
Jonathan E. Zuckerman et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2011)
Docking of a Specialized PIP Box onto Chromatin-Bound PCNA Creates a Degron the Ubiquitin Ligase CRL4Cdt4
Courtney G. Havens et al.
MOLECULAR CELL (2009)
被撤回的出版物: RNA interference targeting the M2 subunit of ribonucleotide reductase enhances pancreatic adenocarcinoma chemosensitivity to gemcitabine (Retracted article. See FEB, 2023)
MS Duxbury et al.
ONCOGENE (2004)
分享论文
